
IndraLab
Statements
Colchicine inhibits NLRP3. 44 / 44
|
1
43
reach
"Martinon F. et al. proved that colchicine can inhibit the activation of the NLRP3 inflammasome in cultured monocytes.34 Current studies have shown that the mechanism of colchicine on the NLRP3 inflammasome can be summarized into the following three types.3.2.1
Colchicine can restrict P2X7 receptor."
reach
"Thus, colchicine inhibits P2X7R, P2X2R, and consequently NLRP3 inflammasome which ultimately attenuates cytokine storm.Antidepressants (paroxetine, duloxetine, fluoxetine) (P2X4 inhibitor)Anti-inflammatory impacts of some antidepressant groups, such as selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs), are a portion of their therapeutic application [132] [133] [134] ."
reach
"More importantly, an alkaloid drug Colchicine which is known for its effects such as tubulin disruption, alteration of E-selectin distribution on endothelial surfaces, inducing loss of adhesion molecule L-selectins and preventing adhesion and recruitment of neutrophil, has also been shown to inhibit activation of the NLRP3 inflammasome."
reach
"However, it is unclear whether colchicine could suppress the activation of NLRP3 inflammasome and cell pyroptosis induced by CC in the progression of AS, and direct evidence for AMPK/SIRT1 activation in antagonizing inflammasome and pyroptosis is still lacking.In this study, we discovered that colchicine could upregulate the expression and activity of various antioxidant enzymes, inhibit ROS production and NLRP3 inflammasome activation, and antagonize endothelial cell pyroptosis which was induced by CC via activating the AMPK-SIRT1 pathway."
reach
"Colchicine, an alkaloid derivative of the Colchicum genus plants, inhibits IL-1β and IL-18 by interacting with the inflammasome Nod-like receptor protein 3 inflammasome protein complex 1 (NLRP-3), for which it is hypothesized that it could be useful in severe Covid-19 Pneumonia [24]."
reach
"Thus, colchicine inhibits P2X7R, P2X2R, and consequently NLRP3 inflammasome which ultimately attenuates cytokine storm.Anti-inflammatory impacts of some antidepressant groups, such as selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs), are a portion of their therapeutic application [132–134]."
reach
"However, colchicine is a microtubule inhibitor and potentially inhibits the NLRP3 inflammasome at various points [2, 19] and has been shown to reduce pro-inflammatory cytokines including interleukin-1β (IL-1β), interleukin-18 (IL-18) and interleukin-6 (IL-6), as well as the inflammatory marker C-reactive protein (CRP) in a variety of experimental models and clinical settings [2, 19]."
reach
"Therefore, it is plausible to suppose that colchicine may upregulate the expression and activity of various antioxidant enzymes and reduce the production of ROS via activating the AMPK-SIRT1 pathway, thus restraining the activation of NLRP3 inflammasome and endothelial cell pyroptosis induced by CC."